# AMP as a Better Delivery System of Adenosine

> **NCT00179010** · PHASE1 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Ischemia

## Interventions

- **DRUG:** Adenosine
- **DRUG:** Adenosine Mono Phosphate (AMP)

## Key facts

- **NCT ID:** NCT00179010
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Study was terminated because funding could not be secured
- **Last updated:** 2019-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179010, "AMP as a Better Delivery System of Adenosine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00179010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*